Table 1 Baseline characteristics of the patients

Gender

Male

8

Female

12

Age

50-59

1

60-69

5

70-79

6

80-89

7

>90

1

Performance Status

0-1

7

4

13

Primary site

Head

9

body/tail

11

Stage

I

1

II

1

III

3

IV

15

Treatment after the onset of Trousseau syndrome

None

14

Gemcitabine

3

Gemcitabine plus nab-Paclitaxel

1

Tegafur-gimeracil-oteracil potassium

2